Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
350 ILa | -11.48% | +9.38% | +149.82% |
Apr. 16 | Pharmocann Global Ltd announced that it has received ILS 0.15554 million in funding | CI |
Mar. 31 | Pharmocann Global Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 22.66M 6.1M 2.27B | Sales 2023 | 14.41M 3.88M 1.44B | Capitalization | 3.12M 841K 312M |
---|---|---|---|---|---|
Net income 2022 | -25M -6.73M -2.5B | Net income 2023 | -9M -2.42M -900M | EV / Sales 2022 | 0.4 x |
Net cash position 2022 | 925K 249K 92.5M | Net cash position 2023 | 768K 207K 76.8M | EV / Sales 2023 | 0.16 x |
P/E ratio 2022 |
-0.26
x | P/E ratio 2023 |
-0.28
x | Employees | 14 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.18% |
1 day | -11.48% | ||
1 week | +9.38% | ||
Current month | -12.26% | ||
1 month | +225.88% | ||
3 months | +94.44% | ||
6 months | +133.33% | ||
Current year | +149.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 19-06-16 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-12-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Sigura
CHM | Chairman | 47 | 22-12-04 |
Locar Gila
BRD | Director/Board Member | 51 | 22-11-28 |
Director/Board Member | 43 | 22-11-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 350 | -11.48% | 3 645 |
24-06-04 | 395.4 | 0.00% | 3,800 |
24-06-02 | 395.4 | -0.88% | 11,239 |
24-05-30 | 398.9 | +24.66% | 6,038 |
24-05-29 | 320 | 0.00% | 6,888 |
Delayed Quote TEL AVIV STOCK EXCHANGE, June 05, 2024 at 10:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+149.82% | 2.74M | |
-.--% | 339M | |
+19.34% | 242M | |
+3.09% | 215M | |
+33.72% | 173M | |
+107.47% | 129M | |
-28.57% | 121M | |
+29.35% | 117M | |
-52.09% | 97.14M | |
0.00% | 86.95M |
- Stock Market
- Equities
- PMCN-M Stock